Aperture Health, Inc. Executes LOI to Acquire Doctors on Call
FAIRFIELD, N.J., June 18, 2012 /PRNewswire/ — Aperture Health, Inc. (OTC APRE) announced today that it has executed a Letter of Intent to acquire Doctors on Call, one of the largest in-home medical practices in New York City. Doctors on Call, consisting of over 35 physicians and physician extenders, is devoted to the care of the frail and/or homebound elderly throughout New York City. Founded in 1968, and available seven (7) days a week, Doctors on Call offers home-based medical care including chronic disease management, laboratory, diagnostic x-ray, ultrasound, podiatry, and annual wellness visits to those incapable of accessing traditional primary care. Further, Doctors on Call has obtained preferential contracts with major Health Maintenance Organizations to provide high quality cost-effective medical care to patients transitioning from the institutional (hospital or skilled nursing facility) to the home setting providing over 2,000 patient visits a month.
The Center for Medicare & Medicaid Innovations has selected Doctors on Call to participate in the Independence at Home Demonstration Project. Among sixteen (16) participating practices nationwide, Doctors on Call was the only medical group in New York City to be selected for this three (3) year project, which is aimed to improve the lives of patients living with chronic illnesses by providing quality medical care right in the patient’s own home.
“We are excited with the affiliation with Aperture Health for it allows Doctors on Call to rapidly expand both its provider network and range of services to include the lower eight (8) counties of New York State as well as New Jersey,” stated Dr. Paul Rosenstock, CEO and Medical Director of Doctors on Call.
Aperture Health is targeting capital for expansion, as well as, marketing and management expertise for Doctors on Call to increase its provider base, to offer in-home specialist services and to establish strategically placed Diagnostic Urgent Care Private Practice Sites. Equipped with the latest in diagnostic radiology and laboratory services and coupled with a highly mobile provider network, these Private Practice Sites will offer Health Plans and local communities a flexible and efficient alternative to the long waits and inconvenience associated with over-crowded emergency rooms. The elderly can thus be visited in the comforts of the home and, if necessary, diagnosed and treated in the Urgent Care Private Practice Site and returned to the home setting at considerable savings in both time and money to all concerned.
James Hennig, R.Ph, Chief Executive Officer and Chairman of the Board of Directors commented, “By combining the clinical and business management expertise of Aperture Health and Doctors on Call, we open additional pathways to medical and pharmaceutical service offerings to homecare patients throughout the NY and NJ areas. Joining forces will allow for a more seamless ‘transitions of care’ process for patients from comprehensive physician evaluation through the initiation of pharmaceutical care at home.”
About Aperture Health, and Triad Therapeutics
Aperture Health through its wholly owned subsidiary Triad Therapeutics operates as a fully JCAHO accredited home IV therapy company, achieving this “gold standard” status in 2007. The company has built a well respected reputation in its industry for its therapy expertise and commitment to care for its patient clients. The company services clients throughout the States of New Jersey, New York and Connecticut, providing opportunity for organic growth. Triad’s full time marketing and sales personnel continuously represent the company in the core services areas, growing and maintaining the company’s referral source base. Patient referrals are made from physicians, hospitals, insurance companies, veterinarians and hospice care providers that have established a professional rapport with Triad.
Certain statements in this news release are forward-looking, including (without limitation) growing revenues and earnings, expected results from current projects and attracting new business. Undue reliance should not be placed on such forward-looking statements because the matters they describe are subject to known and unknown risks, uncertainties and other unpredictable factors, many of which are beyond the Company’s control. The Company’s actual results, performance and trends could differ materially from those indicated or implied by such statements as a result of various factors, including (without limitation) the continued strengthening of Triad’s selling and marketing functions, continued customer satisfaction, contract renewal, new product development, continued availability of capable dedicated personnel, continued cost management, success and availability of acquisitions, availability of financing and other factors, as well as by factors applicable to most companies such as general economic, competitive and other business and civil conditions. Information regarding certain of those and other risk factors and cautionary statements that could affect future results, performance or trends is discussed in the Company’s OTC Disclosure Statement and unaudited management financials posted on www.pinksheets.com. All of the Company’s forward-looking statements are expressly qualified by all such risk factors and other cautionary statements. The information set forth herein speaks only as of the date hereof.
SOURCE Aperture Health, Inc.